A detailed history of Checchi Capital Advisers, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Checchi Capital Advisers, LLC holds 6,507 shares of EW stock, worth $597,602. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,507
Previous 6,533 0.4%
Holding current value
$597,602
Previous $498,000 24.7%
% of portfolio
0.03%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$72.54 - $95.56 $1,886 - $2,484
-26 Reduced 0.4%
6,507 $621,000
Q4 2023

Feb 07, 2024

BUY
$61.71 - $77.76 $43,258 - $54,509
701 Added 12.02%
6,533 $498,000
Q3 2023

Nov 09, 2023

SELL
$69.28 - $93.38 $75,099 - $101,223
-1,084 Reduced 15.67%
5,832 $404,000
Q2 2023

Aug 09, 2023

BUY
$81.41 - $94.33 $18,154 - $21,035
223 Added 3.33%
6,916 $652,000
Q1 2023

May 05, 2023

BUY
$74.26 - $84.51 $48,194 - $54,846
649 Added 10.74%
6,693 $553,000
Q4 2022

Feb 10, 2023

SELL
$68.3 - $87.44 $82,301 - $105,365
-1,205 Reduced 16.62%
6,044 $450,000
Q3 2022

Nov 09, 2022

SELL
$82.37 - $107.29 $22,569 - $29,397
-274 Reduced 3.64%
7,249 $599,000
Q2 2022

Aug 11, 2022

SELL
$86.5 - $128.27 $61,242 - $90,815
-708 Reduced 8.6%
7,523 $756,000
Q1 2022

May 09, 2022

BUY
$101.96 - $128.34 $316,177 - $397,982
3,101 Added 60.45%
8,231 $969,000
Q4 2021

Feb 09, 2022

BUY
$106.37 - $130.68 $6,169 - $7,579
58 Added 1.14%
5,130 $665,000
Q3 2021

Nov 09, 2021

SELL
$102.91 - $122.75 $4,733 - $5,646
-46 Reduced 0.9%
5,072 $574,000
Q2 2021

Aug 06, 2021

BUY
$83.84 - $104.76 $6,455 - $8,066
77 Added 1.53%
5,118 $530,000
Q1 2021

May 10, 2021

BUY
$78.68 - $90.67 $17,230 - $19,856
219 Added 4.54%
5,041 $422,000
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $23,084 - $29,376
322 Added 7.16%
4,822 $440,000
Q3 2020

Nov 10, 2020

SELL
$67.19 - $87.44 $36,215 - $47,130
-539 Reduced 10.7%
4,500 $359,000
Q2 2020

Aug 12, 2020

BUY
$57.54 - $76.95 $186,256 - $249,087
3,237 Added 179.63%
5,039 $348,000
Q1 2020

May 07, 2020

SELL
$52.41 - $81.0 $9,486 - $14,661
-181 Reduced 9.13%
1,802 $340,000
Q4 2019

Feb 07, 2020

BUY
$71.7 - $82.09 $5,592 - $6,403
78 Added 4.09%
1,983 $463,000
Q3 2019

Nov 06, 2019

SELL
$61.55 - $75.43 $18,403 - $22,553
-299 Reduced 13.57%
1,905 $419,000
Q2 2019

Aug 06, 2019

SELL
$55.74 - $64.41 $780 - $901
-14 Reduced 0.63%
2,204 $407,000
Q1 2019

May 09, 2019

BUY
$47.89 - $64.05 $9,242 - $12,361
193 Added 9.53%
2,218 $424,000
Q4 2018

Feb 07, 2019

SELL
$46.41 - $56.94 $14,387 - $17,651
-310 Reduced 13.28%
2,025 $310,000
Q3 2018

Oct 29, 2018

BUY
$45.7 - $58.03 $1,279 - $1,624
28 Added 1.21%
2,335 $407,000
Q2 2018

Aug 06, 2018

SELL
$42.45 - $51.3 $3,056 - $3,693
-72 Reduced 3.03%
2,307 $336,000
Q1 2018

May 01, 2018

BUY
$37.19 - $47.45 $1,301 - $1,660
35 Added 1.49%
2,379 $332,000
Q4 2017

Feb 02, 2018

BUY
$33.79 - $39.39 $79,203 - $92,330
2,344
2,344 $264,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $56.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Checchi Capital Advisers, LLC Portfolio

Follow Checchi Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.